Jasmin Tiro to Papanicolaou Test
This is a "connection" page, showing publications Jasmin Tiro has written about Papanicolaou Test.
Connection Strength
1.285
-
Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result. J Womens Health (Larchmt). 2019 03; 28(3):384-392.
Score: 0.670
-
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
Score: 0.197
-
Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer. 2008 Nov 15; 113(10 Suppl):3013-30.
Score: 0.084
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
Score: 0.055
-
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
Score: 0.051
-
De-implementation of cervical cancer screening before age 21. Prev Med. 2021 12; 153:106815.
Score: 0.051
-
Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV. J Low Genit Tract Dis. 2021 Jan 01; 25(1):43-47.
Score: 0.048
-
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. Prev Med. 2021 04; 145:106410.
Score: 0.048
-
Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 03 15; 144(6):1460-1473.
Score: 0.042
-
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. Contemp Clin Trials. 2018 01; 64:77-87.
Score: 0.039